Durvalumab plus platinum-etoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): A Spanish phase IIIb single arm, real-world study

Paz-Ares, L.Arriola, E.Campelo, M. R. GarciaTain, M. P. DizBlanco, M. C. MartiVega, A. L. MorenoLeon-Mateos, L.Calderon, V. GutierrezHernandez, A. SanchezRodriguez, J. M. OramasMajem, M.De la Rosa, C. AguadoCabellos, R. AlvarezCiriquian, J. L. MartiAmezcua, V.Perez, J. L. FirvidaMellen, A. CallejoBaez, L.Isla, D.2025-01-072025-01-072021-09-210923-7534https://hdl.handle.net/10668/25896enDurvalumab plus platinum-etoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): A Spanish phase IIIb single arm, real-world studyconference outputopen access10.1016/j.annonc.2021.08.2511569-8041https://doi.org/10.1016/j.annonc.2021.08.251700527703212